DaVita Newsroom

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $170

Futu NewsNov 6, 2024 20:31

Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $164

Futu NewsNov 4, 2024 17:33

TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150

Futu NewsNov 1, 2024 20:35

TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150

Futu NewsNov 1, 2024 06:32

DaVita Is Maintained at Equal-Weight by Barclays

Dow JonesNov 1, 2024 02:21

DaVita Analyst Ratings

BenzingaNov 1, 2024 02:11

UBS Adjusts Price Target on DaVita to $186 From $175, Maintains Buy Rating

MT NewswiresOct 31, 2024 23:20

Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $164

Futu NewsOct 31, 2024 17:33

Truist Financial Maintains DaVita(DVA.US) With Hold Rating

Futu NewsOct 30, 2024 19:35

BofA Securities Initiates DaVita(DVA.US) With Sell Rating, Announces Target Price $145

Futu NewsOct 30, 2024 18:31

DaVita Analyst Ratings

BenzingaOct 7, 2024 20:30

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $175

Futu NewsOct 7, 2024 19:31

DaVita Analyst Ratings

BenzingaAug 20, 2024 22:13

Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $165

Futu NewsAug 20, 2024 19:31

Analysts Conflicted on These Healthcare Names: Autolus Therapeutics (AUTL), DaVita (DVA) and Bruker (BRKR)

TipRanksAug 20, 2024 19:25

Key Takeaways From DaVita Analyst Ratings

BenzingaAug 9, 2024 02:02

DaVita Price Target Raised to $175.00/Share From $169.00 by UBS

Dow JonesAug 8, 2024 21:47

DaVita Analyst Ratings

BenzingaAug 8, 2024 01:12

B of A Securities Maintains Underperform on DaVita, Raises Price Target to $145

BenzingaAug 8, 2024 01:12

Bank of America Securities Sticks to Its Sell Rating for DaVita (DVA)

TipRanksAug 7, 2024 21:36